Breaking News, Collaborations & Alliances

WuXi STA, BioLingus Form Technology Collaboration

WuXi STA will have exclusive access to BioLingus technology for sublingual and buccal delivery in the CDMO sector

STA Pharmaceutical Co. (WuXi STA), a subsidiary of WuXi AppTec, and BioLingus have formed an exclusive technology and marketing collaboration for sublingual delivery. Under the terms of the collaboration, WuXi STA will have exclusive access to BioLingus technology for sublingual and buccal delivery in the contract development and manufacturing organization (CDMO) sector. BioLingus has developed a novel platform – with patents secured in major countries around the world – to stabilize and deli...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters